Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
Cbl proto-oncogene C | 0.821 | 0.192 | 4.2E-11 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
RAD21 cohesin complex component | 0.528 | 0.846 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.700 | None | 0.987 | 0 | 0 | 1984 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 0 | 0 | 1986 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.833 | 0 | 0 | 1987 | 2016 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.939 | 0 | 0 | 1987 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 0 | 0 | 1989 | 2019 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.800 | strong | 0.985 | 0 | 0 | 1991 | 2020 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 1.000 | definitive | 0.985 | 0 | 0 | 1992 | 2020 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 1.000 | None | 0.985 | 0 | 0 | 1992 | 2020 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.330 | None | 0.667 | 0 | 0 | 1993 | 2019 | ||||||||
|
GATA binding protein 2 | 0.496 | 0.654 | 0.98 |
|
disease | 0.800 | None | 0.974 | 0 | 0 | 1994 | 2020 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.959 | 0 | 0 | 1994 | 2020 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.800 | strong | 0.981 | 0 | 0 | 1995 | 2019 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
disease | 0.500 | None | 0.980 | 0 | 0 | 1995 | 2019 | ||||||||
|
nucleophosmin 1 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.983 | 0 | 0 | 1996 | 2020 | ||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 1997 | 2013 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2000 | 2020 | ||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.530 | strong | 1.000 | 0 | 0 | 2002 | 2017 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
disease | 0.800 | None | 1.000 | 0 | 0 | 2003 | 2019 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
disease | 0.520 | strong | 1.000 | 0 | 0 | 2003 | 2016 | ||||||||
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
disease | 0.510 | strong | 1.000 | 0 | 0 | 2003 | 2017 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 2003 | 2019 |